Kim Sun-Wook, Baek Ji Yeon, Lee Mirinae, Han Seul-Gi, Kim Woo-Youn, Kim Dahye, Park So Jin, Yun Ji Eun, Jung Hee-Won
Department of Hospital Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
J Korean Med Sci. 2025 Sep 22;40(37):e164. doi: 10.3346/jkms.2025.40.e164.
South Korea is experiencing a rapid increase in the proportion of older adults, leading to a higher prevalence of multimorbidity and polypharmacy. Potentially inappropriate medication (PIM) use among older adults is a growing concern. This study explored the experiences and perceptions of older adults with polypharmacy and PIM and healthcare professionals regarding deprescribing, focusing on barriers, and facilitators.
A qualitative study was conducted from May to August 2023. Participants included 24 older adults aged ≥ 65 years with polypharmacy (≥ 5 medications) and at least one PIM, recruited from tertiary hospitals in South Korea. In-depth interviews were conducted three months after a deprescribing intervention to assess perceptions, experiences, and intervention sustainability. Focus group interviews were also conducted with geriatric healthcare professionals to explore their perspectives on deprescribing.
Participants reported visiting multiple healthcare institutions and receiving prescriptions for various conditions and symptoms, resulting in polypharmacy. They had low awareness of the potential harms of polypharmacy and PIMs. Factors influencing polypharmacy included multimorbidity, symptom relief, health beliefs, and healthcare system factors. Participants emphasized the need for raising public awareness, improving prescribing practices, and implementing a geriatric primary care system. Geriatrics experts highlighted the challenges of deprescribing within the current healthcare system and the lack of systematic support for medication management.
Addressing barriers to deprescribing in South Korea requires a multifaceted approach, including public awareness campaigns, healthcare provider education, prescription sharing systems, and a geriatric primary care system. Long-term policies incentivizing appropriate medication use and supporting deprescribing interventions are necessary for sustainable medication management in older adults.
韩国老年人口比例正在迅速上升,导致多重疾病和多种药物联合使用的患病率更高。老年人潜在不适当用药(PIM)的问题日益受到关注。本研究探讨了患有多种药物联合使用和PIM的老年人以及医疗保健专业人员在减药方面的经历和看法,重点关注障碍和促进因素。
于2023年5月至8月进行了一项定性研究。参与者包括24名年龄≥65岁、患有多种药物联合使用(≥5种药物)且至少有一种PIM的老年人,他们是从韩国的三级医院招募的。在减药干预三个月后进行深入访谈,以评估看法、经历和干预的可持续性。还与老年医疗保健专业人员进行了焦点小组访谈,以探讨他们对减药的看法。
参与者报告称,他们会前往多个医疗机构就诊,并因各种病症和症状而接受处方,从而导致多种药物联合使用。他们对多种药物联合使用和PIM的潜在危害认识不足。影响多种药物联合使用的因素包括多重疾病、症状缓解、健康观念和医疗系统因素。参与者强调需要提高公众意识、改善处方做法并实施老年初级保健系统。老年医学专家强调了在当前医疗系统中进行减药的挑战以及缺乏对药物管理的系统支持。
解决韩国减药的障碍需要采取多方面的方法,包括开展公众宣传活动、对医疗保健提供者进行教育、建立处方共享系统以及建立老年初级保健系统。长期政策激励适当用药并支持减药干预对于老年人可持续的药物管理是必要的。